Victoria M Raymond

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. doi request reprint MLH1 promotor hypermethylation does not rule out a diagnosis of Lynch syndrome: a case report
    Victoria M Raymond
    Department of Internal Medicine, University of Michigan, 300 North Ingalls NI3 A08, Ann Arbor, MI, 48109 5419, USA
    Fam Cancer 14:77-80. 2015
  2. pmc Adrenocortical carcinoma is a lynch syndrome-associated cancer
    Victoria M Raymond
    University of Michigan, Ann Arbor, MI, USA
    J Clin Oncol 31:3012-8. 2013
  3. pmc Elevated risk of prostate cancer among men with Lynch syndrome
    Victoria M Raymond
    University of Michigan, 300 North Ingalls, Ann Arbor, MI 48109 5419, USA
    J Clin Oncol 31:1713-8. 2013
  4. pmc Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma
    Victoria M Raymond
    Division of Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109 5419, USA
    J Clin Endocrinol Metab 98:E119-25. 2013
  5. doi request reprint Genetic counselling and genetic testing in hereditary gastrointestinal cancer syndromes
    Victoria M Raymond
    Department of Internal Medicine, University of Michigan, 300 North Ingalls, Ann Arbor, MI 48109 0419, USA
    Best Pract Res Clin Gastroenterol 23:275-83. 2009
  6. pmc Risk of pancreatic cancer in families with Lynch syndrome
    Fay Kastrinos
    Department of Internal Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
    JAMA 302:1790-5. 2009
  7. pmc Hereditary prostate cancer as a feature of Lynch syndrome
    Christina M Bauer
    Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA
    Fam Cancer 10:37-42. 2011
  8. doi request reprint Outcomes of genetic evaluation for hereditary cancer syndromes in unaffected individuals
    Shanna L Gustafson
    Division of Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan, 300 North Ingalls SPC 5419, NI3 A08, Ann Arbor, MI, 48109, USA
    Fam Cancer 14:167-74. 2015
  9. pmc A review of statistical methods for testing genetic anticipation: looking for an answer in Lynch syndrome
    Philip S Boonstra
    Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA
    Genet Epidemiol 34:756-68. 2010
  10. pmc The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3)
    Tobias Else
    Department of Internal Medicine, Divisions of Metabolism Endocrinology and Diabetes T E, R J A, Molecular Medicine and Genetics J N E, V M R, and Gastroenterology E M S, Department of Human Genetics M L M, and Department of Otolaryngology Head and Neck Surgery H A A at the University of Michigan Hospital and Health Systems, Ann Arbor, Michigan 48109 and Norris Cancer Center S B G, University of Southern California, Los Angeles, California 90033
    J Clin Endocrinol Metab 99:E1482-6. 2014

Collaborators

Detail Information

Publications16

  1. doi request reprint MLH1 promotor hypermethylation does not rule out a diagnosis of Lynch syndrome: a case report
    Victoria M Raymond
    Department of Internal Medicine, University of Michigan, 300 North Ingalls NI3 A08, Ann Arbor, MI, 48109 5419, USA
    Fam Cancer 14:77-80. 2015
    ..We describe a patient with multiple primary cancers, a deleterious germline MSH6 mutation and somatic MLH1 promotor hypermethylation highlighting the importance of incorporating the clinical history with the genetic evaluation. ..
  2. pmc Adrenocortical carcinoma is a lynch syndrome-associated cancer
    Victoria M Raymond
    University of Michigan, Ann Arbor, MI, USA
    J Clin Oncol 31:3012-8. 2013
    ..The association of adult-onset ACC with inherited cancer predisposition syndromes is poorly understood. Our study sought to define the prevalence of Lynch syndrome (LS) among patients with ACC...
  3. pmc Elevated risk of prostate cancer among men with Lynch syndrome
    Victoria M Raymond
    University of Michigan, 300 North Ingalls, Ann Arbor, MI 48109 5419, USA
    J Clin Oncol 31:1713-8. 2013
    ..Previous studies quantifying prostate cancer risk in LS have provided conflicting results...
  4. pmc Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma
    Victoria M Raymond
    Division of Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109 5419, USA
    J Clin Endocrinol Metab 98:E119-25. 2013
    ..Although existing criteria advocate for TP53 testing in all patients with ACC regardless of age at diagnosis, the overall prevalence of germline mutations in patients diagnosed with ACC has not been well studied...
  5. doi request reprint Genetic counselling and genetic testing in hereditary gastrointestinal cancer syndromes
    Victoria M Raymond
    Department of Internal Medicine, University of Michigan, 300 North Ingalls, Ann Arbor, MI 48109 0419, USA
    Best Pract Res Clin Gastroenterol 23:275-83. 2009
    ..We also provide guidelines for referral to cancer genetics clinics and for promoting discussions about genetic counselling and genetic testing...
  6. pmc Risk of pancreatic cancer in families with Lynch syndrome
    Fay Kastrinos
    Department of Internal Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
    JAMA 302:1790-5. 2009
    ..A number of extracolonic tumors have been associated with the disorder, including pancreatic cancer; however, the risk of pancreatic cancer in Lynch syndrome is uncertain and not quantified...
  7. pmc Hereditary prostate cancer as a feature of Lynch syndrome
    Christina M Bauer
    Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA
    Fam Cancer 10:37-42. 2011
    ..However prostate tumors in known MMR mutation carriers did display MSI and loss of gene expression suggesting that PCa may arise in Lynch Syndrome due to defective DNA mismatch repair...
  8. doi request reprint Outcomes of genetic evaluation for hereditary cancer syndromes in unaffected individuals
    Shanna L Gustafson
    Division of Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan, 300 North Ingalls SPC 5419, NI3 A08, Ann Arbor, MI, 48109, USA
    Fam Cancer 14:167-74. 2015
    ....
  9. pmc A review of statistical methods for testing genetic anticipation: looking for an answer in Lynch syndrome
    Philip S Boonstra
    Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA
    Genet Epidemiol 34:756-68. 2010
    ..An expanded dataset from the Danish HNPCC-register is analyzed by this alternative set of methods...
  10. pmc The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3)
    Tobias Else
    Department of Internal Medicine, Divisions of Metabolism Endocrinology and Diabetes T E, R J A, Molecular Medicine and Genetics J N E, V M R, and Gastroenterology E M S, Department of Human Genetics M L M, and Department of Otolaryngology Head and Neck Surgery H A A at the University of Michigan Hospital and Health Systems, Ann Arbor, Michigan 48109 and Norris Cancer Center S B G, University of Southern California, Los Angeles, California 90033
    J Clin Endocrinol Metab 99:E1482-6. 2014
    ..Although the phenotypes associated with the more commonly mutated genes, SDHB and SDHD, are well described, less is known about SDHC-associated paragangliomas...
  11. pmc First description of parathyroid disease in multiple endocrine neoplasia 2A syndrome
    James C Sisson
    Department of Radiology, Division of Nuclear Medicine, University of Michigan Health System, UH B1 G505D, Ann Arbor, MI 48109 0028, USA
    Endocr Pathol 19:289-93. 2008
    ..The initial report of the proband preceded the publications defining both MTC and MEN 2A. The values of in-depth family histories and genetic analyses are exemplified...
  12. doi request reprint Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome
    Victoria M Raymond
    Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109 2200, USA
    Fam Cancer 11:115-21. 2012
    ..Pathology review is essential for accurate diagnosis of a hereditary cancer syndrome in the setting of familial renal cancer...
  13. pmc Traditional roles in a non-traditional setting: genetic counseling in precision oncology
    Jessica N Everett
    Department of Internal Medicine, University of Michigan, 300 North Ingalls, NI3A16, Ann Arbor, MI, 48109, USA
    J Genet Couns 23:655-60. 2014
    ....
  14. doi request reprint Pediatric duodenal cancer and biallelic mismatch repair gene mutations
    Sumita Roy
    Division of Pediatric Hematology Oncology, Dept of Pediatrics, University of Michigan Health System, Ann Arbor, Michigan 48109 0238, USA
    Pediatr Blood Cancer 53:116-20. 2009
    ..We report the case of a 16-year-old female with duodenal adenocarcinoma and past history of medulloblastoma found to have a novel germline bialleleic truncating mutation (c.[949C>T]+[949C>T]) of the PMS2 gene...
  15. doi request reprint Familial gastric and pancreatic cancers
    Victoria M Raymond
    From the Divisions of Gastroenterology and Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
    Am Soc Clin Oncol Educ Book 2013:44-8. 2013
    ..Clinical challenges include identifying high risk individuals who would be most likely to benefit from screening and determining which screening modalities and intervals would be most effective...
  16. doi request reprint Familial medullary thyroid carcinoma associated with cutaneous lichen amyloidosis
    Amy E Rothberg
    Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109 5354, USA
    Thyroid 19:651-5. 2009
    ..This is a report of a patient with a novel genotype-phenotype relationship of a c804 mutation of the RET proto-oncogene manifesting as medullary thyroid carcinoma (MTC) and cutaneous lichen amyloidosis (CLA)...